Search for a trial

Extension 1 to Protocol
A 2 year extension to a 36-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of aliskiren on the prevention of left ventricular remodeling in high risk post-acute myocardial infarction patients when added to optimized standard therapy

The primary objective of this 2 year extension study (CSPP100A2340E1) is to provide additional long-term safety data in this patient population as a post marketing commitment to the EMEA. A secondary objective is to provide additional follow-up data…

Surgical Septal Myectomy versus Percutaneous Transluminal Alcohol Septal Ablation in Patients with Hypertrophic Obstructive Cardiomyopathy

The aim of this registry is to compare functional status among patients with highly symptomatic obstructive HCM despite optimal medical treatment who undergo Alcohol Septal Ablation to Surgical Septal Myectomy. This study will therefore, compare the…